Delivery Order SPE2DE24D0013-SPE2D626F740M
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,800 on December 8, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order (4570200478) is set to be completed by December 15, 2025, with performance occurring at Cepheid's Sunnyvale facility. The award falls under an existing Indefinite Delivery Contract (IDC) with the Department of Veterans Affairs VISN 17,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a delivery order valued at $3,240 from the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with ultimate completion targeted for November 7, 2025. This firm fixed-price delivery order, issued under contract 4569883320 (GXTV-10), carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $2,236.22 firm fixed-price delivery order from the Defense Logistics Agency Medical Supply Chain on November 25, 2025, with an ultimate completion date of December 3, 2025. The delivery order, designated as contract 4570109826, is for a Kit Xpert Spec Clt 10 Tst Ct N Gnrrh—a diagnostic test cartridge product aligned with Cepheid's GeneXpert diagnostic platform capabilities. This award...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,208 firm fixed-price delivery order (Contract No. XPRSTREPA-10) by the Medical Supply Chain, a Defense agency component, with a completion deadline of October 3, 2025. This delivery order was issued without a set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award falls under Cepheid's existing federal contracting relationship with defense...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F740MDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,208 on December 3, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The order is classified as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and carries no set-aside designation. The contract is associated with Cepheid's broader federal contracting relationship, through which the company supplies diagnostic reagents, test kits, and molecular diagnostic solutions to multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. Cepheid has established itself as a primary federal supplier of diagnostic solutions through its GeneXpert diagnostic platform and associated molecular testing capabilities. The company currently holds substantial indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030 and a $6.74 million contract with VISN 17 through December 2029, which serve as the primary vehicles for ongoing procurement of diagnostic reagents, test kits, and maintenance services across the federal healthcare system. This modest delivery order represents continued procurement activity under Cepheid's established federal contracting relationships for molecular diagnostic testing supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/2/25 |